semaglutide or tirzepatide for weight loss vs Semaglutide: A Showdown Semaglutide and Tirzepatide for Diabetes

Its become foundational to how we practice medicine and deliver care. Big disparities GLP-1 drugs were introduced to manage blood sugar in patients with type 2 diabetes, beginning with the approval of Byetta in 2005, followed by Ozempic in 2017 and Mounjaro in 2024

Alexandra Sowa, an Internal Medicine physician focused on obesity treatment, launched a GLP-1 Support System which includes packages of fibre, protein, and electrolyte powders meant to help ease common side effects like nausea and dizziness

Studies to reveal importance of Fe for Cd tolerance in Brassica juncea

Int J Mol Sci (2023) 24:2696

May the next documentary be filled with good screening practices, proper education, and most importantly, patient safety as the priority.